ADVFN US – Market Content Editor

Veeva Systems (NYSE:VEEV) shares soared 15% after the company released first-quarter results that exceeded Wall Street expectations and issued optimistic guidance for both the upcoming quarter and full fiscal year 2026. The company reported earnings per share of $1.97 for Q1, beating analysts’ forecasts by $0.23. Revenue reached $759 million, outperforming the consensus estimate of…

Agilent Technologies (NYSE:A) saw its stock rise over 5% in pre-market trading on Thursday after the company released stronger-than-expected second-quarter results and reaffirmed its full-year guidance for fiscal 2025, despite ongoing challenges such as tariff-related costs and mixed performance across different customer sectors. The company posted revenue of $1.67 billion for the quarter, topping analyst…

First-time claims for U.S. unemployment benefits rose by more than expected in the week ended May 24th, according to a report released by the Labor Department on Thursday. The report said initial jobless claims climbed to 240,000, an increase of 14,000 from the previous week’s revised level of 226,000. Economists had expected jobless claims to…

The major U.S. index futures on the Dow Jones, S&P and Nasdaq are currently pointing to a higher open on Thursday, with stocks likely to move back to the upside after ending yesterday’s choppy trading session mostly lower. Early buying interest is likely to be generated in reaction to news that a federal court blocked…

Taysha Gene Therapies (NASDAQ:TSHA) saw its stock surge 19% after unveiling critical updates on the design of its pivotal trial for TSHA-102, a gene therapy candidate for treating Rett Syndrome. The trial plans, backed by encouraging data from Part A of the REVEAL study and informed by IRSF natural history findings, received written alignment from…

Intellia Therapeutics (NASDAQ:NTLA) saw its stock tumble by 19% after releasing a safety update related to its Phase 3 MAGNITUDE trial for the investigational gene-editing therapy, nex-z, aimed at treating transthyretin amyloidosis with cardiomyopathy (ATTR-CM). The decline followed a disclosure of a serious but asymptomatic adverse event involving a patient who experienced Grade 4 elevations…

U-Haul Holding Company (NYSE:UHAL), the parent of U-Haul International, reported a larger-than-expected fourth-quarter loss on Thursday, even as its revenue exceeded analyst projections. The results come amid continued pressure from elevated fleet replacement costs. Following the earnings announcement, U-Haul shares rose 1.09% in pre-market trading. For the quarter ended March 31, 2025, the company posted…

Teva Pharmaceutical Industries (NYSE:TEVA) reaffirmed its long-term financial outlook on Thursday, maintaining its goal of reaching a 30% operating profit margin by 2027. The company remains confident in its growth trajectory, driven by a mix of new product innovations and continued strength in its generics segment. A core focus of Teva’s strategy is expanding its…

The U.S. economy has experienced a mild contraction, with the latest data showing Gross Domestic Product (GDP) falling by 0.2% on an annualized basis. While this marks a downturn, it came in slightly better than economists’ expectations, which had predicted a 0.3% decline. GDP, which measures the inflation-adjusted value of all goods and services produced…

Shares of Best Buy (NYSE:BBY) slipped 2% in premarket trading Thursday after the company lowered its fiscal 2026 guidance due to tariff-related headwinds, despite posting better-than-expected results for its first quarter. The tech retailer reported earnings per share (EPS) of $1.15 for the quarter, surpassing analyst expectations of $1.07. Revenue declined about 1% year-over-year to…